Literature DB >> 10679682

Preparation, solubility, and cytocompatibility of zinc-releasing calcium phosphate ceramics.

A Ito1, K Ojima, H Naito, N Ichinose, T Tateishi.   

Abstract

Zinc is an essential trace element with stimulatory effects on bone formation. Therefore, zinc was doped into beta-tricalcium phosphate to develop zinc-releasing biomaterials to promote bone formation. The zinc-doped beta-tricalcium phosphate, beta-tricalcium phosphate, and hydroxyapatite powders were mixed at a (Ca+Zn)/P molar ratio of 1.60, followed by sintering into a dense body at 1100 degrees C for 1 h. The sintered body was a composite ceramic consisting of zinc-doped beta-tricalcium phosphate and hydroxyapatite phases. The composite ceramic contained zinc oxide when the zinc content was higher than 1.20 wt %. The composite ceramic released zinc under pseudophysiological conditions. However, the release of calcium and phosphate decreased with an increase in zinc content in a range higher than 0.12 wt % owing to a decrease in solubility of the zinc-doped beta-tricalcium phosphate phase. Proliferation of osteoblastic MC3T3-E1 cells was significantly increased on the composite ceramic with a zinc content from 0.6 to 1.20 wt %, compared with those without zinc. When the zinc content was higher than 1.20 wt %, release of zinc from the zinc oxide caused cytotoxicity. Therefore, the zinc content of the composite ceramic must be <1.20 wt %. Copyright 2000 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10679682     DOI: 10.1002/(sici)1097-4636(200005)50:2<178::aid-jbm12>3.0.co;2-5

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  28 in total

1.  Substituted hydroxyapatites for bone repair.

Authors:  Jennifer H Shepherd; David V Shepherd; Serena M Best
Journal:  J Mater Sci Mater Med       Date:  2012-03-03       Impact factor: 3.896

Review 2.  Bioactive ceramic-based materials with designed reactivity for bone tissue regeneration.

Authors:  Chikara Ohtsuki; Masanobu Kamitakahara; Toshiki Miyazaki
Journal:  J R Soc Interface       Date:  2009-01-20       Impact factor: 4.118

3.  Design of an inorganic dual-paste apatite cement using cation exchange.

Authors:  Marc Bohner; Hanna Tiainen; Pascal Michel; Nicola Döbelin
Journal:  J Mater Sci Mater Med       Date:  2015-01-29       Impact factor: 3.896

4.  Nonlinear Oscillatory Dynamics of the Hardening of Calcium Phosphate Bone Cements.

Authors:  Vuk Uskoković; Julietta V Rau
Journal:  RSC Adv       Date:  2017-08-21       Impact factor: 3.361

5.  Zinc-substituted hydroxyapatite: a biomaterial with enhanced bioactivity and antibacterial properties.

Authors:  E S Thian; T Konishi; Y Kawanobe; P N Lim; C Choong; B Ho; M Aizawa
Journal:  J Mater Sci Mater Med       Date:  2012-11-16       Impact factor: 3.896

6.  Effects of phosphate-based glasses on T lymphocytes in vitro.

Authors:  A Kesisoglou; J C Knowles; I Olsen
Journal:  J Mater Sci Mater Med       Date:  2002-12       Impact factor: 3.896

7.  Hydrothermal synthesis of hydroxyapatite from natural source.

Authors:  S Jinawath; D Pongkao; M Yoshimura
Journal:  J Mater Sci Mater Med       Date:  2002-05       Impact factor: 3.896

8.  Long-term biocompatibility evaluation of 0.5 % zinc containing hydroxyapatite in rabbits.

Authors:  Rodrigo F B Resende; Gustavo V O Fernandes; Sílvia R A Santos; Alexandre M Rossi; Inayá Lima; José M Granjeiro; Mônica D Calasans-Maia
Journal:  J Mater Sci Mater Med       Date:  2013-04-21       Impact factor: 3.896

9.  Processing, characterisation, and biocompatibility of zinc modified metaphosphate based glasses for biomedical applications.

Authors:  Ensanya Ali Abou Neel; Luke Austin O'Dell; Mark Edmund Smith; Jonathan Campbell Knowles
Journal:  J Mater Sci Mater Med       Date:  2007-12-01       Impact factor: 3.896

10.  Structural characterization of zinc-substituted hydroxyapatite prepared by hydrothermal method.

Authors:  Ming'Ou Li; Xiufeng Xiao; Rongfang Liu; Cuiyu Chen; Lizhong Huang
Journal:  J Mater Sci Mater Med       Date:  2007-08-01       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.